Dientamoeba fragilis: comparison of prevalence between gastroenteritis cases and healthy controls Multi-centre, case-control study (2010-2012; the Netherlands):

Slides:



Advertisements
Similar presentations
Rotavirus vaccines Contentious issues and the way forward.
Advertisements

תזונה בינקות כהתחלה טובה לחיים הכינוס המדעי השני יום רביעי 14 במאי 2008, ט " ז באייר תשס " ח.
Tuberculosis incidence and risk factors among adult patients receiving HAART in Senegal: a 7-year cohort study Assane DIOUF et al. IRD/UMR 145 CRCF, CHNU.
Observational Studies and RCT Libby Brewin. What are the 3 types of observational studies? Cross-sectional studies Case-control Cohort.
Randomised Clinical Trial: Lactobacillus reuteri DSM vs. Placebo in Children With Acute Diarrohea Aliment Pharmacol Ther 2012:36 (4): R. Francavilla.
DO HEALTHY CHILDREN NEED TO GET VACCINATED?. Rationale for childhood vaccination Annual influenza vaccine is widely recommended for children at high risk.
Case-Control Studies (Retrospective Studies). What is a cohort?
Journal Club Alcohol, Other Drugs, and Health: Current Evidence July–August 2013.
Efficacy of fidaxomicin vs vancomycin for C. difficile-associated diarrhoea (CDAD) in pts with cancer Post-hoc analysis of 2 multi-centre, double-blind.
ICS in COPD – A Risk Factor for CAP? Rate of pneumonia in ICS Studies
Pseudo Outbreak of Group A Strep (GAS) at Concord Hospital A Collaborative Review Review Participants IP, ID, Lab, Micro, QA, Materials Management, Lean,
Comunicación y Gerencia 1Case control studies15/12/2010.
BIOSTATISTICS 5.5 MEASURES OF FREQUENCY BIOSTATISTICS TERMINAL OBJECTIVE: 5.5 Prepare a Food Specific Attack Rate Table IAW PEF 5.5.
1 Suppressive Valacyclovir Therapy Soon After Initial Genital Herpes: Clinical Efficacy and Impact on Herpes-Related Quality of Life Hunter Handsfield.
METHODOLOGY Observational transversal multicentric study 1 Gynecologist survey on Emergency Contraception in France (end of 2012)
CHARM-Preserved: Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity - Preserved Purpose To determine whether the angiotensin.
BEAUTI f UL: morBidity-mortality EvAlUaTion of the I f inhibitor ivabradine in patients with coronary disease and left ventricULar dysfunction Purpose.
Randomized, double-blind, multicenter, controlled trial.
Impact of adenovirus (Ad) vaccine on clinical presentation and epidemiology of respiratory pathogens associated with upper respiratory infection (URI)
Impact of double dose vs standard dose oseltamivir on clinical and virological outcomes in pts with severe influenza Multi-centre, double-blind RCT (South.
The use of Probiotics in the prevention of Antibiotic-Associated Diarrhea Evidence Based Medicine Lindsey Bowman.
Epidemiology of invasive meningococcal disease in the Netherlands and impact of serogroup C vaccination National surveillance data (Netherlands Reference.
Overview of Hepatitis B, C, and D Epidemiology in Eastern Europe and the Newly Independent States Michael O. Favorov MD, Ph.D., D.Sc. CDC Central Asia.
Comparison of NNRTI vs NNRTI  ENCORE  EFV vs RPV –ECHO-THRIVE –STAR  EFV vs ETR –SENSE.
Specific Aim 1: Determine the impact of psychiatric disorders on the hospital length of stay (LOS) in pediatric patients diagnosed with SCD admitted for.
Corticosteroids in adults with bacterial meningitis
S ystolic H eart failure treatment with the I f inhibitor ivabradine T rial Main results Swedberg K, et al. Lancet. 2010;376(9744):
Inappropriate empirical antimicrobial Tx for coagulase-negative staphylococcal (CoNS) bacteraemia: impact on survival Single-centre retrospective cohort.
How to Analyze Therapy in the Medical Literature (part 2)
Multi-centre, retrospective cohort study in 308 nursing homes reporting ≥1 confirmed or suspected norovirus outbreak (USA; ) Primary endpoints:
Effect of prolonging Clostridium difficile (CD) treatment on recurrence rate in patients receiving concomitant systemic antibiotic therapy 5-yr retrospective.
Best first ? The ATAC completed treatment analysis Professor Jack Cuzick Wolfson Institute of Preventive Medicine, London, UK.
Extended duration of injection interval. 2 Lucas et al. Efficacy of lanreotide Autogel ® administered every 4–8 weeks in patients with acromegaly previously.
Laura Mucci, Pharm.D. Candidate Mercer University 2012 Preceptor: Dr. Rahimi February 2012.
New antibiotics against Gram-positive pathogens for acute bacterial skin and skin-structure infections (ABSSSIs) 3 international, multi-centre, double-blind,
Comparison of NNRTI vs NNRTI  ENCORE  EFV vs RPV –ECHO-THRIVE –STAR  EFV vs ETR –SENSE.
Copyright restrictions may apply JAMA Pediatrics Journal Club Slides: Probiotic in Colic, Regurgitation, & Constipation Indrio F, Di Mauro A, Riezzo G,
Long-term mortality after acute stroke  Stroke is a leading cause of mortality: 6 million fatal events annually worldwide.  Mainly affects elderly, but.
Lecture 9: Analysis of intervention studies Randomized trial - categorical outcome Measures of risk: –incidence rate of an adverse event (death, etc) It.
PDG-PET/CT vs MRI: diagnostic value for spondylodiscitis Retrospective study ( ): N=70 pts with a clinical suspicion of spondylodiscitis or an.
Concerns About Adverse Event Reporting in Randomized Clinical Trials Yusuf Yazıcı, MD NYU Hospital for Joint Diseases
N Engl J Med 2010; 362: January 28, 2010 Presenters ; Dr Ngwenya/Dr Nchimba.
Hospital Based Surveillance to Estimate the Burden of Rotavirus Gastroenteritis Among European Children Younger than 5 Years of Age Johannes Foster, Alfredo.
Group A streptococcal (GAS) pharyngitis: food-borne outbreak
Frequency of Clostridium difficile infection (CDI) transmission via ward contact with a known case Retrospective, observational study (22 months; 1 laboratory.
Case Control Studies Dr Amna Rehana Siddiqui Department of Family and Community Medicine October 17, 2010.
Short-term efficacy of nicotine replacement therapy (NRT) for smoking cessation among adolescents and the role of compliance Charlotte Scherphof* Regina.
Journal Club – Hepa Visite Catharina Zeuzem
"Epidemiological Features of Rotavirus Infection among children below 5 years old in Jordan, Rationale for Vaccine Introduction,2015" Kareman Juma`ah Al-Zain.
Caspofungin prophylaxis vs placebo, followed by preemptive Tx for invasive candidiasis (IC) in ICU pts: MSG-01 study Multi-centre, double-blind, phase.
Frequency of Clostridium difficile transmission by asymptomatic carriers during hospital admission Study 1: Transmission by asymptomatically colonised.
Accutane ® Use and Epidemiology John E. La Flore, MD, MSPH Vice President, Drug Safety & Risk Management Hoffmann-La Roche Inc.
Lactobacillus reuteri DSM for the management of infantile colic in breastfed infants A randomized, double-blind, placebo-controlled trial.
Department of Preventive Medicine Faculty of Public Health University of Debrecen General Practitioners’ Morbidity Sentinel Stations Program (GPMSSP) to.
Suicide and self-harm in people with bipolar disorder Better Care for People with Bipolar Disorder Manchester January 2015 Nav Kapur The Centre for Suicide.
Hadziyannis SJ et al. EASL Peginterferon alfa-2a (40KD) (PEGASYS ® ) in combination with ribavirin (RBV): efficacy and safety results from a phase.
Hepatitis web study Hepatitis web study Elbasvir + Grazoprevir in GT 1 and Chronic Renal Disease C-SURFER Phase 3 Treatment Naïve and Treatment Experienced.
Case Control study. An investigation that compares a group of people with a disease to a group of people without the disease. Used to identify and assess.
Trial profile for the pharmacokinetics and pharmacodynamics study in patients with dyslipidaemia (A) and the ambulatory blood pressure study (B) *Participants.
GLAGOV Trial design: Patients with CAD and elevated LDL cholesterol on statin therapy were randomized to subcutaneous evolocumab (n = 484) vs. subcutaneous.
EVITA Trial design: Smokers admitted with an acute coronary syndrome were randomized to varenicline 1 mg twice daily (n = 151) vs. placebo (n = 151). Study.
Trial profile John A Dormandy et al. Lancet 2005;366:
SIGNIFY Trial design: Participants with stable coronary artery disease without clinical heart failure and resting heart rate >70 bpm were randomized to.
Volume 382, Issue 9900, Pages (October 2013)
CHAMPION Trial design: Patients with recent hospitalization for heart failure were implanted with a pulmonary artery pressure monitor and randomized so.
Measures of risk and association
Box plots showing the relative difference in distribution of mtDNA copy number per cell between patients with ESRD and healthy control subjects frequency.
Difference in the risk of MACEs in patients treated with anti–IL17 agents compared with the placebo in RCTs. IL,interleukin; MACEs, major adverse cardiovascular.
Frequencies of diagnoses (% of all previous inpatient visits) of inpatient visits before abuse hospitalizations. Frequencies of diagnoses (% of all previous.
Difference in the risk of MACEs in patients treated with anti-IL23 agents compared with the placebo in RCTs. IL, interleukin; MACEs, major adverse cardiovascular.
Presentation transcript:

Dientamoeba fragilis: comparison of prevalence between gastroenteritis cases and healthy controls Multi-centre, case-control study ( ; the Netherlands): Cases: N=1,542 stool samples from pts visiting their general practitioner because of gastrointestinal (GI) complaints Controls: N=1,203 stool samples from patients without GI complaints or from family or laboratory technicians Cases/controls: matched for age, month of sample collection, sex, region Sample analysis: multiplex real-time PCR Cases with D. fragilis have less diarrhoea than cases without D. fragilis: de Boer M. ECCMID 2014 abs. O051 1 of 2 Data from oral presentation

Difference between cases and controls remains if: –Only D. fragilis studied (no coinfection): Cases: 17.8%; Controls: 32.4% –Laboratory staff and family excluded from analysis (D. fragilis prevalence among 39 lab technicians in control group: 62%) Dientamoeba fragilis: comparison of prevalence between gastroenteritis cases and healthy controls A positive PCR finding of D. fragilis should be interpreted with caution, given the higher prevalence in controls than in gastroenteritis cases de Boer M. ECCMID 2014 abs. O051 2 of 2 Data from oral presentation

Lactobacilli and bifidobacteria: impact on prevention of antibiotic-associated diarrhoea (AAD) and C.difficile diarrhoea (CDD) PLACIDE study: multi-centre, double-blind RCT: N=2,941 inpatients ≥65 yr exposed to ≥1 oral or parenteral antibiotics: –Multi-strain preparation of lactobacilli and bifidobacteria (total 6x organisms) 1x/day for 21 days: N=1,470 –Placebo: N=1,471 Allen SJ et al. Lancet 2013;382: of 2

Lactobacilli and bifidobacteria: impact on prevention of antibiotic-associated diarrhoea (AAD) and C.difficile diarrhoea (CDD) Median duration of hospital admission: 4 days for both groups (P=0.87) Serious adverse events (SAE): 19.7% of participants; frequency similar in both groups; no SAE attributed to study participation Meta-analysis: current RCT + 4 additional RCTs in pts ≥65 yr: In inpatients ≥65 yr, a multi-strain preparation of lactobacilli and bifidobacteria does not seem to prevent occurrence of ADD or CDD Allen SJ et al. Lancet 2013;382: of 2